Tokyo Tape
Sign in
← Taiyo Holdings

Quarterly report · Q3

4626.TEDINET S100SPJ2
Period2023-04-01 → 2023-12-31
Filed2024-02-02
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥78.0bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥97.3bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥76.8bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥14.3bn2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥14.3bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥13.8bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥15.5bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥13.9bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥13.8bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥13.9bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥10.2bn2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥11.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥10.3bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥10.2bn2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥10.3bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥204.6bnat 2023-12-31Cons.Assets
Total assets¥187.3bnat 2023-03-31Cons.Assets
Total assets¥190.1bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥104.1bnat 2023-12-31Cons.Liabilities
Total liabilities¥94.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥100.4bnat 2023-12-31Cons.Net assets
Net assets / equity¥92.7bnat 2023-03-31Cons.Net assets
Net assets / equity¥91.3bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥49.8bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥47.1bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥182.542023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥70.882023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥203.712022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥184.092022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥50.672022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio49.1%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio49.5%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio48.0%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-12-31¥2.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-12-31¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-12-31¥244m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31¥47m
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue2023-04-01 → 2023-12-31¥53.3bn
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue external2023-04-01 → 2023-12-31¥53.3bn
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥0
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentsegment profit2023-04-01 → 2023-12-31¥12.4bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentrevenue2023-04-01 → 2023-12-31¥22.1bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentrevenue external2023-04-01 → 2023-12-31¥22.1bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentsegment profit2023-04-01 → 2023-12-31¥2.9bn
—segment totalrevenue2023-04-01 → 2023-12-31¥75.4bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥75.4bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥0
—segment totalsegment profit2023-04-01 → 2023-12-31¥15.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥78.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥78.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥244m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥15.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥2.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥2.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥217m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31¥1m
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue2022-04-01 → 2022-12-31¥55.3bn
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue external2022-04-01 → 2022-12-31¥55.3bn
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥0
jpcrp040300-q3r_E00913-000Electronics Materialsreportable segmentsegment profit2022-04-01 → 2022-12-31¥14.2bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentrevenue2022-04-01 → 2022-12-31¥18.9bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentrevenue external2022-04-01 → 2022-12-31¥18.9bn
jpcrp040300-q3r_E00913-000Medical And Pharmaceuticalreportable segmentsegment profit2022-04-01 → 2022-12-31¥1.4bn
—segment totalrevenue2022-04-01 → 2022-12-31¥74.2bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥74.2bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥0
—segment totalsegment profit2022-04-01 → 2022-12-31¥15.5bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥77.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥76.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥217m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥15.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 345
ItemContextValueUnit
Notes and accounts payable tradePrior1YearInstant6513000000JPY
Notes and accounts payable tradeCurrentQuarterInstant10496000000JPY
Short term loans payablePrior1YearInstant5424000000JPY
Short term loans payableCurrentQuarterInstant7884000000JPY
Current portion of long term loans payablePrior1YearInstant12902000000JPY
Current portion of long term loans payableCurrentQuarterInstant33364000000JPY
Income taxes payablePrior1YearInstant1031000000JPY
Income taxes payableCurrentQuarterInstant1525000000JPY
Provision for bonusesPrior1YearInstant1108000000JPY
Provision for bonusesCurrentQuarterInstant635000000JPY
Other provision clPrior1YearInstant87000000JPY
Other provision clCurrentQuarterInstant471000000JPY
Other clPrior1YearInstant8047000000JPY
Other clCurrentQuarterInstant6049000000JPY
Current liabilitiesPrior1YearInstant35115000000JPY
Current liabilitiesCurrentQuarterInstant60426000000JPY
Long term loans payablePrior1YearInstant53174000000JPY
Long term loans payableCurrentQuarterInstant38953000000JPY
Net defined benefit liabilityPrior1YearInstant108000000JPY
Net defined benefit liabilityCurrentQuarterInstant94000000JPY
Other provision nclPrior1YearInstant55000000JPY
Other provision nclCurrentQuarterInstant49000000JPY
Other nclPrior1YearInstant6069000000JPY
Other nclCurrentQuarterInstant4599000000JPY
Noncurrent liabilitiesPrior1YearInstant59407000000JPY
Noncurrent liabilitiesCurrentQuarterInstant43697000000JPY
LiabilitiesPrior1YearInstant94523000000JPY
LiabilitiesCurrentQuarterInstant104123000000JPY
Capital stockPrior1YearInstant9761000000JPY
Capital stockCurrentQuarterInstant9903000000JPY
Capital surplusPrior1YearInstant14883000000JPY
Capital surplusCurrentQuarterInstant15025000000JPY
Retained earningsPrior1YearInstant67561000000JPY
Retained earningsCurrentQuarterInstant72724000000JPY
Treasury stockPrior1YearInstant-6107000000JPY
Treasury stockCurrentQuarterInstant-5993000000JPY
Shareholders equityPrior1YearInstant86098000000JPY
Shareholders equityCurrentQuarterInstant91660000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant429000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant769000000JPY
Foreign currency translation adjustmentPrior1YearInstant6223000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant8021000000JPY
Remeasurements of defined benefit plansPrior1YearInstant-14000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant-14000000JPY
Valuation and translation adjustmentsPrior1YearInstant6637000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant8777000000JPY
Non controlling interestsPrior1YearInstant3000000JPY
Non controlling interestsCurrentQuarterInstant4000000JPY
Net assetsPrior1YearInstant92739000000JPY
Net assetsCurrentQuarterInstant100442000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass